The board of optometry and pharmacy quality assurance commission will use a joint process to determine changes to the oral drug list that includes a means to resolve disagreements.

(1) Categories of medications approved by the Food and Drug Administration may be added to WAC 246-851-580(1) by rule through consultation and approval of the board of optometry and pharmacy quality assurance commission.

(2) Medications approved by the Food and Drug Administration in categories that are within the scope of optometric physician practice that are not included in WAC 246-851-580(1) may be added through consultation and approval of the board of optometry and the pharmacy quality assurance commission. Approval will follow the joint process established by the board and commission.

(3) WAC 246-851-580 and 246-851-590 may be updated to reflect additions or removal of medications.